Tag: Bright Minds

Debra BorchardtFebruary 27, 2023
shutterstock_757996678.jpg

5min00
Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) provided an update on its clinical programs, anticipated upcoming milestones, and strategic priorities for advancing its development pipeline of innovative treatments to heal the central nervous system (CNS) and brain through the regulation of serotonin. Bright Minds has two psychedelic compound drugs called BMB-101 and BMB-202. BMB-101 The company […]

StaffNovember 28, 2022
daily-hit.jpg

5min00
The Daily Hit is a recap of cannabis business news for Nov. 28, 2022. ON THE SITE Veterans’ Plight Spotlights Need for Cannabis Legalization as Congress Moves Research Bill As a historic House-passed cannabis research bill makes its way to President Joe Biden’s desk after surviving a Senate vote, questions remain regarding its impact on […]

StaffNovember 28, 2022
shutterstock_256424509-1280x853.jpg

3min00
Despite the challenges of raising capital these days in the cannabis and psychedelics industry, two companies managed to close deals before the end of the year. Trees The Canadian-based Trees Corp. (NEO: Tree) completed the closing of a non-brokered private placement of 745 units at a price of $1,000 per unit for gross proceeds of approximately $745,000. The […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.